Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma
Fig 7
Morphologic MRI data sets of a representative animal from the control group at baseline and follow-up.
Balb/c nude mouse. A: baseline. B: follow-up. Tumor indicated by red dashed line. Note the tumor volume increase from baseline to follow-up.